Add One More Weapon to Cholera’s Deadly Arsenal
Interdisciplinary researchers discover a new membrane-dissolving toxin that V. cholerae injects into cells, giving science a possible new direction for battling the pathogen
Radiation therapy has been — and will be — a cornerstone of cancer treatment for good reason: It works.
Mostly.
Currently, more than half of cancer patients receive radiation as part of their treatment. But 20 percent of them, give or take, will find that they need different options because their tumors are resistant to radiation therapy. It’s a bad place to be: They may still face the potential side effects without the therapeutic benefit, and they’ve lost precious time.